Model
Edge
Alnylam Pharmaceuticals, Inc.
0001819573
Filing type
3
Filing date
Jun 2, 2026
Updated
Jun 3, 2026 ยท 2:21 PM
Copy reference
Filing
3
Initial Statement of Beneficial Ownership